CN114948174A - Intelligent pulsed electric field ablation system for controlling output channel - Google Patents
Intelligent pulsed electric field ablation system for controlling output channel Download PDFInfo
- Publication number
- CN114948174A CN114948174A CN202210583013.0A CN202210583013A CN114948174A CN 114948174 A CN114948174 A CN 114948174A CN 202210583013 A CN202210583013 A CN 202210583013A CN 114948174 A CN114948174 A CN 114948174A
- Authority
- CN
- China
- Prior art keywords
- ablation
- impedance
- electrode
- detection
- electric field
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002679 ablation Methods 0.000 title claims abstract description 138
- 230000005684 electric field Effects 0.000 title claims abstract description 63
- 238000001514 detection method Methods 0.000 claims abstract description 65
- 230000008859 change Effects 0.000 claims abstract description 45
- 230000000007 visual effect Effects 0.000 claims abstract description 3
- 238000013507 mapping Methods 0.000 claims description 19
- 230000000747 cardiac effect Effects 0.000 claims description 15
- 230000007831 electrophysiology Effects 0.000 claims description 11
- 238000002001 electrophysiology Methods 0.000 claims description 11
- 239000008280 blood Substances 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 claims description 8
- 230000005284 excitation Effects 0.000 claims description 7
- 238000011282 treatment Methods 0.000 claims description 7
- 210000004375 bundle of his Anatomy 0.000 claims description 4
- 210000001013 sinoatrial node Anatomy 0.000 claims description 4
- 210000001992 atrioventricular node Anatomy 0.000 claims description 3
- 238000004891 communication Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 210000001519 tissue Anatomy 0.000 description 26
- 238000010586 diagram Methods 0.000 description 16
- 238000000034 method Methods 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 11
- 230000000694 effects Effects 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 8
- 230000008569 process Effects 0.000 description 5
- 230000003902 lesion Effects 0.000 description 4
- 210000004413 cardiac myocyte Anatomy 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 230000002427 irreversible effect Effects 0.000 description 3
- 208000001871 Tachycardia Diseases 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 206010049447 Tachyarrhythmia Diseases 0.000 description 1
- 238000003782 apoptosis assay Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 238000013153 catheter ablation Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000004070 electrodeposition Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 210000005061 intracellular organelle Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000005522 programmed cell death Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00613—Irreversible electroporation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00875—Resistance or impedance
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Otolaryngology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgical Instruments (AREA)
Abstract
Description
技术领域technical field
本发明属于脉冲电场消融技术领域,特别是涉及一种智能的控制输出通道的脉冲电场消融系统。The invention belongs to the technical field of pulse electric field ablation, in particular to an intelligent pulse electric field ablation system for controlling an output channel.
背景技术Background technique
现有治疗快速心律失常往往采用射频、冷冻等热消融技术。其中射频技术可以产生固定频率的正弦波。所产生的射频能量通过射频导管或者射频电极作用到需要治疗的病灶点,使其达到阻断或者调理的作用,进而达到治疗的效果。而冷冻消融是通过冷冻球囊内液态制冷剂的蒸发过程吸热,使消融靶点周围温度骤然降低。通过低温使病灶区域的组织细胞受损或死亡,进而达到治疗的目的。这些消融技术在临床实际应用中受限于热池效应,很难达到全层透壁的消融目标,同时这些消融技术不具备细胞的选择性,因此会将非靶的细胞也一并进行消融损毁。Existing treatments for tachyarrhythmias often use thermal ablation techniques such as radiofrequency and cryoablation. Among them, radio frequency technology can generate a sine wave with a fixed frequency. The generated radio frequency energy acts on the lesion to be treated through the radio frequency catheter or the radio frequency electrode, so as to achieve the effect of blocking or conditioning, thereby achieving the effect of treatment. In contrast, cryoablation absorbs heat through the evaporation process of the liquid refrigerant in the cryo-balloon, so that the temperature around the ablation target is suddenly lowered. Through low temperature, the tissue cells in the lesion area are damaged or killed, so as to achieve the purpose of treatment. The clinical application of these ablation techniques is limited by the thermal pool effect, and it is difficult to achieve full-thickness transmural ablation goals. At the same time, these ablation techniques do not have cell selectivity, so non-target cells will also be ablated and destroyed. .
鉴于以上热消融技术的缺陷,脉冲电场消融技术作为一项非热消融技术日渐得到了临床应用的关注。脉冲电场消融技术是通过产生一种脉宽为毫秒、微秒甚至纳秒级的高压脉冲电场,在短时间内释放极高的能量,其能使得细胞膜甚至是细胞内的细胞器如内质网、线粒体、细胞核等会产生大量的不可逆的微孔。进而造成病变细胞的凋亡,从而达到预期的治疗目的。In view of the above-mentioned defects of thermal ablation technology, pulsed electric field ablation technology as a non-thermal ablation technology has received increasing attention in clinical application. The pulsed electric field ablation technology is to generate a high-voltage pulsed electric field with a pulse width of milliseconds, microseconds or even nanoseconds, and release extremely high energy in a short period of time, which can make cell membranes and even intracellular organelles such as endoplasmic reticulum, endoplasmic reticulum, etc. Mitochondria, nuclei, etc. will produce a large number of irreversible micropores. And then cause the apoptosis of the diseased cells, so as to achieve the expected therapeutic purpose.
在治疗快速心律失常的应用中,采用脉冲电场消融技术可以选择性的处理心肌细胞,而不对其他非靶的细胞组织产生影响,同时其还具有彻底的全层消融、精准、快速、保护冠脉的特点。因此脉冲电场消融技术有望成为理想的心脏消融手段。In the application of the treatment of tachyarrhythmia, the use of pulsed electric field ablation technology can selectively treat cardiomyocytes without affecting other non-target cells and tissues. specialty. Therefore, pulsed electric field ablation technology is expected to become an ideal means of cardiac ablation.
现有技术中,通常消融设备需要结合电生理三维标测系统进行使用,消融设备对病灶输出能量,引起病灶的转变,而电生理三维标测系统通过采集信号,对消融过程进行监控,例如,电生理三维标测系统可以将消融的点进行标注,这样可以直观的显示消融的位置,操作者根据电生理三维标测系统显示的回传数据及时调整消融设备的参数和消融的方向。In the prior art, the ablation device usually needs to be used in combination with an electrophysiological three-dimensional mapping system. The ablation device outputs energy to the lesion to cause the transformation of the lesion, and the electrophysiological three-dimensional mapping system monitors the ablation process by collecting signals, for example, The electrophysiological 3D mapping system can mark the ablation points, so that the ablation position can be displayed intuitively, and the operator can adjust the parameters of the ablation equipment and the ablation direction in time according to the returned data displayed by the electrophysiological 3D mapping system.
采用脉冲电场放电消融以后,通常是脉冲电场放电是在多个电极间放电完成脉冲能量输出,而不是单点消融,因此,基于单点消融情况下通过压力传感器反馈消融效果,在电生理三维标测系统进行消融点标注的方式不再适用于多个电极间放电的脉冲电场,需要针对高压脉冲消融进行改进,提供一种新的反馈消融效果的系统。After pulsed electric field discharge ablation is used, usually pulsed electric field discharge discharges between multiple electrodes to complete pulse energy output, rather than single-point ablation. Therefore, based on single-point ablation, the pressure sensor is used to feedback the ablation effect. The method of marking the ablation points of the measurement system is no longer suitable for the pulsed electric field discharged between multiple electrodes. It is necessary to improve the high-voltage pulse ablation and provide a new system for feedback of the ablation effect.
发明内容SUMMARY OF THE INVENTION
针对现有的电生理三维标测系统消融点标注方法无法准确反映高压脉冲信号的多点消融的效果的问题,本发明选用了新的参数,例如阻抗值、PH值和介电常数,根据这些参数的变化,反映高压脉冲消融的状态和效果,因此,提出了一种智能的控制输出通道的脉冲电场消融系统。In view of the problem that the existing ablation point labeling method of the electrophysiological three-dimensional mapping system cannot accurately reflect the effect of multi-point ablation of high-voltage pulse signals, the present invention selects new parameters, such as impedance value, pH value and dielectric constant, according to these The change of parameters reflects the state and effect of high-voltage pulse ablation. Therefore, a pulsed electric field ablation system with intelligent control of the output channel is proposed.
为了实现上述发明目的,本发明提供了以下技术方案:In order to achieve the above-mentioned purpose of the invention, the present invention provides the following technical solutions:
一种智能的控制输出通道的脉冲电场消融系统,包括脉冲电场消融仪和多电极脉冲消融导管,An intelligent pulsed electric field ablation system with output channel control, comprising a pulsed electric field ablation instrument and a multi-electrode pulsed ablation catheter,
所述多电极脉冲消融导管根据所述脉冲电场消融仪的检测结果,开启或关闭输出高压脉冲信号的通道;所述多电极脉冲消融导管还用于导管处的阻抗信号、PH值采集信号和/或介电常数信号的采集;The multi-electrode pulse ablation catheter opens or closes a channel for outputting high-voltage pulse signals according to the detection result of the pulse electric field ablation instrument; the multi-electrode pulse ablation catheter is also used for impedance signals at the catheter, pH value acquisition signals and/or Or the acquisition of dielectric constant signal;
所述脉冲电场消融仪,根据所述阻抗信号进行阻抗检测,根据所述PH值采集信号进行PH值检测,根据介电常数信号进行介电常数检测,通过阻抗检测、PH值检测、介电常数检测中的一种或几种检测结果,判断高压脉冲信号作用到人体组织后的消融状态,所述消融状态用于可视化标记。The pulsed electric field ablation instrument performs impedance detection according to the impedance signal, performs pH value detection according to the pH value acquisition signal, and performs dielectric constant detection according to the dielectric constant signal. One or more of the detection results in the detection determine the ablation state after the high-voltage pulse signal acts on the human tissue, and the ablation state is used for visual marking.
作为本发明的优选方案,所述消融状态包括未穿孔和穿孔,当消融状态为穿孔时,输出高压脉冲的通道关闭,当消融状态为未穿孔,输出高压脉冲的通道保持开启状态。As a preferred solution of the present invention, the ablation state includes non-perforation and perforation. When the ablation state is perforated, the channel for outputting high-voltage pulses is closed, and when the ablation state is non-perforated, the channel for outputting high-voltage pulses remains open.
作为本发明的优选方案,所述阻抗检测包括阻抗值的检测和阻抗变化率的检测,As a preferred solution of the present invention, the impedance detection includes the detection of the impedance value and the detection of the impedance change rate,
所述阻抗值在第一阻抗阈值范围以及阻抗变化率在第一变化率范围,则输出高压脉冲的电极在血池中,未与人体组织贴靠;If the impedance value is within the first impedance threshold value range and the impedance change rate is within the first change rate range, the electrode outputting the high-voltage pulse is in the blood pool and is not in contact with human tissue;
所述阻抗值在第二阻抗阈值范围以及阻抗变化率在第二变化率范围,则输出高压脉冲的电极与人体组织贴靠。When the impedance value is within the second impedance threshold value range and the impedance change rate is within the second change rate range, the electrode outputting the high-voltage pulse is in contact with the human tissue.
作为本发明的优选方案,用于阻抗检测的阻抗信号的获取方法为:向所述多电极脉冲消融导管的电极加载频率为2KHz到200KHz的信号,采集所述2KHz到200KHz的信号作用在电极后的回传信号,将所述回传信号通过滤波处理,转化为阻抗信号。As a preferred solution of the present invention, the method for acquiring the impedance signal used for impedance detection is as follows: load a signal with a frequency of 2KHz to 200KHz on the electrode of the multi-electrode pulse ablation catheter, collect the signal from 2KHz to 200KHz and act on the electrode after the electrode is collected. The return signal is converted into an impedance signal through filtering processing.
作为本发明的优选方案,在输出高压脉冲的电极与人体组织贴靠的前提下,若所述PH值检测的结果为变化幅度在±0.5的范围内,则消融状态为穿孔。As a preferred solution of the present invention, on the premise that the electrode outputting the high-voltage pulse is in contact with human tissue, if the result of the pH value detection is that the variation range is within the range of ±0.5, the ablation state is perforation.
作为本发明的优选方案,在输出高压脉冲的电极与人体组织贴靠的前提下,若介电常数检测的结果在预设的介电常数范围,则消融状态为穿孔。As a preferred solution of the present invention, on the premise that the electrode outputting the high-voltage pulse is in contact with human tissue, if the dielectric constant detection result is within the preset dielectric constant range, the ablation state is perforation.
作为本发明的优选方案,用于介电常数检测的介电常数信号获取的方法为:As a preferred solution of the present invention, the method for obtaining the dielectric constant signal for dielectric constant detection is:
将正弦激励信号通过所述多电极脉冲消融导管的电极作用于人体组织,所述正弦激励信号的频率范围是5KHz-300MHz,获取不同频率正弦激励信号作用于人体组织后回传的复阻抗电信号,所述复阻抗电信号为介电常数信号。The sinusoidal excitation signal is applied to human tissue through the electrodes of the multi-electrode pulse ablation catheter. The frequency range of the sinusoidal excitation signal is 5KHz-300MHz, and the complex impedance electrical signal returned after the sinusoidal excitation signal of different frequencies acts on the human tissue is obtained. , the complex impedance electrical signal is a dielectric constant signal.
作为本发明的优选方案,在输出高压脉冲的电极与人体组织未贴靠的前提下,PH值检测的结果为变化幅度在±0.5的范围内,并且介电常数检测的结果在预设的介电常数范围,则消融状态为穿孔。As a preferred solution of the present invention, on the premise that the electrode outputting the high-voltage pulse is not in contact with the human tissue, the result of the pH value detection is that the variation range is within the range of ±0.5, and the result of the dielectric constant detection is within the preset dielectric constant. The electric constant range, the ablation state is perforation.
作为本发明的优选方案,若阻抗变化率、PH值变化率以及介电常数变化率趋于稳定,则消融状态为穿孔。As a preferred solution of the present invention, if the impedance change rate, the pH value change rate, and the dielectric constant change rate tend to be stable, the ablation state is perforation.
作为本发明的优选方案,还包括心脏电生理三维标测系统,As a preferred solution of the present invention, it also includes a cardiac electrophysiological three-dimensional mapping system,
所述心脏电生理三维标测系统与所述脉冲电场消融仪通信连接,用于在心脏三维图像中显示消融状态标记;The cardiac electrophysiology three-dimensional mapping system is connected in communication with the pulsed electric field ablation instrument, and is used for displaying ablation status marks in the three-dimensional heart image;
所述心脏电生理三维标测系统还用于检测关键传导信号,所述关键传导信号来自于窦房结、房室结或希氏束,并将所述关键传导信号输出到所述脉冲电场消融仪;脉冲电场消融仪关断与所述关键传导信号相关的高压脉冲信号的通道。The cardiac electrophysiology three-dimensional mapping system is also used to detect key conduction signals, the key conduction signals come from the sinoatrial node, atrioventricular node or His bundle, and output the key conduction signals to the pulsed electric field ablation instrument; the pulsed electric field ablation instrument shuts off the channel of the high-voltage pulse signal related to the key conduction signal.
与现有技术相比,本发明的有益效果:Compared with the prior art, the beneficial effects of the present invention:
本发明的系统根据电极阻抗、PH值和介电常数,反映出当前高压脉冲消融中各电极处人体组织的状态,准确反映高压脉冲信号的多点消融的效果。According to the electrode impedance, pH value and dielectric constant, the system of the invention reflects the state of human tissue at each electrode in the current high-voltage pulse ablation, and accurately reflects the multi-point ablation effect of the high-voltage pulse signal.
附图说明Description of drawings
图1为本发明实施例1中一种智能控制输出通道的脉冲电场消融系统的系统连接框图;1 is a system connection block diagram of a pulsed electric field ablation system for intelligently controlling an output channel in Embodiment 1 of the present invention;
图2是本发明实施例1中一种智能控制输出通道的脉冲电场消融系统的原理框图;2 is a schematic block diagram of a pulsed electric field ablation system for intelligently controlling an output channel in Embodiment 1 of the present invention;
图3是本发明实施例1中阻抗检测方案分类示意图;3 is a schematic diagram of classification of impedance detection schemes in Embodiment 1 of the present invention;
图4是本发明实施例1中分时切换检测示意图;4 is a schematic diagram of time-sharing handover detection in Embodiment 1 of the present invention;
图5是本发明实施例1中分频切换检测示意图;5 is a schematic diagram of frequency division switching detection in Embodiment 1 of the present invention;
图6是本发明实施例1中融合提取检测示意图;6 is a schematic diagram of fusion extraction detection in Embodiment 1 of the present invention;
图7是本发明实施例1中pH检测方案示意图;7 is a schematic diagram of a pH detection scheme in Example 1 of the present invention;
图8为本发明实施例1中介电检测方案示意图;8 is a schematic diagram of a dielectric detection scheme in Embodiment 1 of the present invention;
图9是本发明实施例1中可变形态的球状多电极脉冲电场消融导管结构图;9 is a structural diagram of a spherical multi-electrode pulsed electric field ablation catheter with variable shape in Example 1 of the present invention;
图10是本发明实施例1中可变形态的球状多电极脉冲电场消融导管扩张图;FIG. 10 is an expansion diagram of a spherical multi-electrode pulsed electric field ablation catheter with variable shape in Example 1 of the present invention;
图11是本发明实施例1中可变形态的球状多电极脉冲电场消融导管扩张整列示意图;11 is a schematic diagram of the expansion and alignment of the spherical multi-electrode pulsed electric field ablation catheter with variable shape in Example 1 of the present invention;
图12是本发明实施例1中环形多电极脉冲电场消融导管示意图;12 is a schematic diagram of a ring-shaped multi-electrode pulsed electric field ablation catheter in Embodiment 1 of the present invention;
图13是本发明实施例1中环形多电极脉冲电场消融导管拉伸示意图;13 is a schematic diagram of the stretching of the annular multi-electrode pulsed electric field ablation catheter in Embodiment 1 of the present invention;
图14是本发明实施例1中可变形态的环形多电极脉冲电场消融导管示意图;14 is a schematic diagram of a variable-shape annular multi-electrode pulsed electric field ablation catheter in Example 1 of the present invention;
图15是本发明实施例1中可变形态的环形多电极脉冲电场消融导管(带导丝)远端示意图;15 is a schematic diagram of the distal end of a variable-shape annular multi-electrode pulsed electric field ablation catheter (with a guide wire) in Example 1 of the present invention;
图16是本发明实施例1中心脏电生理三维标测系统消融点标记示例。FIG. 16 is an example of ablation point marking of the cardiac electrophysiology three-dimensional mapping system in Embodiment 1 of the present invention.
具体实施方式Detailed ways
下面结合试验例及具体实施方式对本发明作进一步的详细描述。但不应将此理解为本发明上述主题的范围仅限于以下的实施例,凡基于本发明内容所实现的技术均属于本发明的范围。The present invention will be further described in detail below in conjunction with test examples and specific embodiments. However, it should not be construed that the scope of the above-mentioned subject matter of the present invention is limited to the following embodiments, and all technologies realized based on the content of the present invention belong to the scope of the present invention.
实施例1Example 1
一种智能的控制输出通道的脉冲电场消融系统的框图以及实现原理如图1-2所示。可以在这个系统中配套使用的多电极脉冲电场消融导管如图9-15所示。下面是详细的实现过程。The block diagram and realization principle of a pulsed electric field ablation system that intelligently controls the output channel are shown in Figure 1-2. A multi-electrode pulsed electric field ablation catheter that can be used with this system is shown in Figures 9-15. The following is the detailed implementation process.
1、多电极脉冲电场消融导管在血池里的阻抗与在贴靠组织的阻抗是有一定差异的,同时导管在移动过程中,贴靠程度的变化可以在阻抗的变化率上有一定的反应。因此可以通过各个电极极间的阻抗判断当前是否与组织贴靠,同时通过阻抗的变化率反应组织贴靠程度。1. There is a certain difference between the impedance of the multi-electrode pulsed electric field ablation catheter in the blood pool and the impedance of the adjacent tissue. At the same time, during the movement of the catheter, the change of the degree of contact can have a certain response to the rate of change of the impedance. . Therefore, it can be judged whether it is currently in contact with the tissue through the impedance between the electrodes, and at the same time, the degree of tissue abutment can be reflected by the rate of change of the impedance.
2、当进行了脉冲电场放电后的组织,由于会产生不可逆的电穿孔,造成细胞的程序性死亡。这些会反应到消融位置的阻抗值的下降、PH值的变化、介电常数的变化等。但是当脉冲电场消融到一定的程度,这些的变化就会较缓慢,达到一定的平衡,因为此时在此电场强度下能造成不可逆电穿孔的心肌细胞已经被处理完毕,再继续消融已经没有多大的意义。因此,可以在每次消融后实时的检测当前消融位置的阻抗值变化情况、PH值的变化、介电常数的变化等,判断当前点位是否还需要进行脉冲电场消融。2. When the tissue is discharged by the pulsed electric field, it will cause the programmed cell death due to irreversible electroporation. These will reflect a drop in impedance at the ablation site, a change in pH, a change in dielectric constant, etc. However, when the pulsed electric field is ablated to a certain extent, these changes will be slower and reach a certain balance, because the cardiomyocytes that can cause irreversible electroporation under this electric field intensity have already been processed, and there is not much to continue ablation. meaning. Therefore, after each ablation, the impedance value change, pH value change, dielectric constant change, etc. of the current ablation position can be detected in real time, to determine whether the current point needs to be pulsed electric field ablation.
3、为了避免脉冲电场消融对重要组织的传导细胞(如窦房结、希氏束等)造成影响,就需要有效地识别电极周边的电生理信号,在周围电生理信号识别有风险的电极就避免进行放电。3. In order to avoid the impact of pulsed electric field ablation on conductive cells of important tissues (such as sinoatrial node, His bundle, etc.), it is necessary to effectively identify the electrophysiological signals around the electrodes, and identify the risky electrodes in the surrounding electrophysiological signals. Avoid discharging.
4、这里阻抗检测可以有以下几种方式,分时切换检测、融合提取检测、分频切换检测。这里的检测信号通常的加载频率为2Khz到200Khz,通过将回采得到的电信号通过滤波处理转化为实际的阻抗信号,具体如图3-图6所示。阻抗值为150欧姆认为电极与组织贴靠,进行高压脉冲消融后,消融十次,阻抗值减少40-50欧,说明是有效消融点。当电极在血池中时,阻抗为100欧,但是当电极与人体组织贴靠时,阻抗值为200欧,不仅通过阻抗值来反映贴靠状态,还用阻抗变化率反映贴靠状态,在血池中,阻抗变化率低一些,与人体组织贴靠的时候,阻抗变化率要高一些,通过阻抗变化率不仅反映出电极和人体的贴靠程度,还反映出电极与组织的相对位置关系。4. The impedance detection can be performed in the following ways: time-division switching detection, fusion extraction detection, and frequency-division switching detection. The detection signal here usually has a loading frequency of 2Khz to 200Khz, and the electrical signal obtained by the extraction is converted into an actual impedance signal through filtering, as shown in Figure 3-Figure 6. When the impedance value is 150 ohms, it is considered that the electrode is close to the tissue. After high-voltage pulse ablation is performed ten times, the impedance value decreases by 40-50 ohms, indicating that it is an effective ablation point. When the electrode is in the blood pool, the impedance is 100 ohms, but when the electrode is attached to human tissue, the impedance value is 200 ohms. Not only the impedance value is used to reflect the attachment state, but also the impedance change rate is used to reflect the attachment state. In the blood pool, the impedance change rate is lower. When it is close to the human tissue, the impedance change rate is higher. The impedance change rate not only reflects the degree of contact between the electrode and the human body, but also reflects the relative position relationship between the electrode and the tissue. .
5、PH检测通常采用PH传感器,通过通道切换的方式分时加载检测不同电极所对应区域的PH值,例如PH值在±0.5的范围内稳定,则说明穿孔完毕,无须再进行消融,另外,检测NA离子的浓度高,PH值偏高,当细胞穿孔后,细胞内的钾离子外溢出来,PH值下降,说明系统已经透壁穿孔,消融完成,是有效的消融点。5. PH detection usually uses a PH sensor, and the PH value of the corresponding area of different electrodes is detected by time-sharing through channel switching. For example, if the PH value is stable within the range of ±0.5, it means that the perforation is completed and no further ablation is required. In addition, It is detected that the concentration of NA ions is high and the pH value is high. When the cells are perforated, the potassium ions in the cells overflow and the pH value drops, indicating that the system has perforated through the wall and the ablation is completed, which is an effective ablation point.
6、介电常数的检测利用的是5KHz-300MHz中多个频率的正弦激励信号,激发反应细胞组织在不同频率信号下所对应的复阻抗电信号的变化。而这些信号通过傅里叶变化等方法转换成频域的信号。可以得到不同类型的细胞甚至离子在某一频率下的频域信号,该频域信号是能够反应其变化的特征值,以此值作为介电常数判断的依据。通过几种参数如心肌细胞的介电常数、NA离子,CA离子,K离子介电常数的变化即可在一定程度上反应脉冲电场消融后该区域细胞组织的变化。6. The detection of dielectric constant uses sinusoidal excitation signals with multiple frequencies in the range of 5KHz-300MHz to stimulate and respond to changes in complex impedance electrical signals corresponding to cells and tissues under different frequency signals. These signals are converted into signals in the frequency domain by methods such as Fourier transform. The frequency domain signals of different types of cells and even ions at a certain frequency can be obtained. The frequency domain signal is a characteristic value that can reflect its changes, and this value is used as the basis for judging the dielectric constant. Changes in the dielectric constant of cardiomyocytes, NA ions, CA ions, and K ions, can reflect the changes in the area of cells after pulsed electric field ablation to a certain extent.
进一步的,阻抗检测包括阻抗值的检测和阻抗变化率的检测,Further, the impedance detection includes the detection of the impedance value and the detection of the impedance change rate,
当阻抗值在第一阻抗阈值范围以及阻抗变化率在第一变化率范围,则输出高压脉冲的电极在血池中,未与人体组织贴靠。第一阻抗阈值范围为100~150欧姆;阻抗变化率的第一变化率范围是阻抗变化率远大于50欧/0.5秒。When the impedance value is within the first impedance threshold value range and the impedance change rate is within the first change rate range, the electrode outputting the high-voltage pulse is in the blood pool and is not in contact with the human tissue. The first impedance threshold range is 100-150 ohms; the first change rate range of the impedance change rate is that the impedance change rate is much larger than 50 ohms/0.5 seconds.
所述阻抗值在第二阻抗阈值范围以及阻抗变化率在第二变化率范围,则输出高压脉冲的电极与人体组织贴靠。阻抗值的第二阻抗阈值范围是200欧姆左右,阻抗变化率的第二变化率范围为50欧/0.5秒左右。When the impedance value is within the second impedance threshold value range and the impedance change rate is within the second change rate range, the electrode outputting the high-voltage pulse is in contact with the human tissue. The second impedance threshold range of the impedance value is about 200 ohms, and the second change rate range of the impedance change rate is about 50 ohms/0.5 seconds.
进一步的,在输出高压脉冲的电极与人体组织贴靠的前提下,若所述PH值检测的结果为变化幅度在±0.5的范围内,则仅采用PH值检测的结果这一项就能判断出消融状态为穿孔。Further, under the premise that the electrode outputting the high-voltage pulse is in contact with the human tissue, if the result of the pH value detection is within the range of ±0.5, then only the result of the pH value detection can be used to judge. The ablation state is perforation.
进一步的,在输出高压脉冲的电极与人体组织贴靠的前提下,若介电常数检测的结果在预设的介电常数范围(例如K离子介电常数为100),则消融状态为穿孔。Further, on the premise that the electrode outputting the high voltage pulse is in contact with the human tissue, if the dielectric constant detection result is within the preset dielectric constant range (for example, the K ion dielectric constant is 100), the ablation state is perforation.
另外,在输出高压脉冲的电极与人体组织未贴靠的前提下,需要同时满足PH值检测的结果为变化幅度在±0.5的范围内,并且介电常数检测的结果在预设的介电常数范围,才能判断消融状态为穿孔。In addition, under the premise that the electrodes that output high-voltage pulses are not in contact with human tissue, it is necessary to meet the requirements that the pH value detection result is within the range of ±0.5, and the dielectric constant detection result is within the preset dielectric constant. range, the ablation state can be judged as perforation.
7、电生理信号主要是通过带通的滤波采集电路对电极回路上所指示的电生理信号进行采集,并通过算法判断识别。7. The electrophysiological signal mainly collects the electrophysiological signal indicated on the electrode circuit through a band-pass filter acquisition circuit, and judges and identifies it through an algorithm.
7.1、具体的智能输出通道控制就是基于图1-3所示。脉冲电场消融仪具备阻抗检测、PH检测以及介电常数检测的功能,而电生理信号的识别是通过脉冲电场消融仪将耗材导管与心脏电生理三维标测系统建立的实现的。7.1. The specific intelligent output channel control is based on the one shown in Figure 1-3. The pulsed electric field ablation instrument has the functions of impedance detection, PH detection and dielectric constant detection, and the identification of electrophysiological signals is realized by establishing the consumable catheter and the cardiac electrophysiological three-dimensional mapping system through the pulsed electric field ablation instrument.
7.2脉冲电场消融仪通过阻抗检测判断当前的阻抗情况,以此为依据识别当前电极所处的位置是否具是血池。如果是该处的电极将不会放电。保证了不会在贴靠血池的情况下做无意义的放电。7.2 The pulse electric field ablation instrument judges the current impedance situation through impedance detection, and identifies whether the current electrode position is a blood pool based on this. If it is there the electrode will not discharge. It is guaranteed that there will be no meaningless discharge in the case of sticking to the blood pool.
7.3脉冲电场消融仪通过阻抗检测可以识别当前电极阻抗的变化率,当变化率出现较大的变化或者较大来回的波动时,可以以此判断当前电极的贴靠不稳定甚至贴靠程度下降,这时候此处的电极不应进行放电,以免降低放电的效果。直到通过操作导管,脉冲电场消融仪通过阻抗检测判断此位置贴靠良好,才会启动。7.3 The pulse electric field ablation instrument can identify the change rate of the current electrode impedance through impedance detection. When the change rate has a large change or a large back-and-forth fluctuation, it can be used to judge that the current electrode is unstable or even the degree of adhesion is decreased. At this time, the electrodes here should not be discharged, so as not to reduce the effect of the discharge. It will not be activated until the pulsed electric field ablation instrument judges that the position is well attached through impedance detection by operating the catheter.
7.4脉冲电场消融仪还会通过阻抗检测、PH检测、介电常数检测等手段,在每次放电后判断当前电极消融的阻抗的特性。当综合以上的参数情况,当阻抗值、PH值以及介电常数的变化率以及波动趋于稳定,就认为当前的电极所处的区域已经无需再进行消融。脉冲电场消融仪会根据此结果断开此电极通路,不再进行消融,直至导管移动到其他的区域,脉冲电场能消融仪才会使得该电极通路的能量输出功能。7.4 The pulse electric field ablation instrument will also judge the impedance characteristics of the current electrode ablation after each discharge by means of impedance detection, PH detection, dielectric constant detection, etc. When the above parameters are combined, when the impedance value, pH value, and the rate of change and fluctuation of the dielectric constant tend to be stable, it is considered that the region where the current electrode is located no longer needs to be ablated. The pulsed electric field ablation instrument will disconnect the electrode path according to the result, and will not perform ablation until the catheter moves to other areas, and the pulsed electric field energy ablation instrument will make the energy output function of the electrode path.
7.5通过脉冲电场消融仪将多电极消融导管与心脏电生理三维标测系统建立的通路,就可以进行多电极导管的电生理信号监测。当心脏电生理三维标测系统识别到某些电极通路上的电生理信号为关键传导信号,如窦房结、房室结或希氏束等。心脏电生理三维标测系统通过通信总线及时传送给脉冲电场消融仪,脉冲电场消融仪断开根据心脏电生理三维标测系统所确定的需要保护的电极通路,保证能量输出不会通过此电极通路,有效保证了消融的安全性。7.5 The multi-electrode ablation catheter and the cardiac electrophysiological three-dimensional mapping system are established through the path established by the pulsed electric field ablation instrument, and the electrophysiological signal monitoring of the multi-electrode catheter can be carried out. When the cardiac electrophysiology 3D mapping system recognizes that the electrophysiological signals on some electrode pathways are key conduction signals, such as the sinoatrial node, the atrioventricular node or the bundle of His. The cardiac electrophysiology 3D mapping system is sent to the pulsed electric field ablation instrument in time through the communication bus, and the pulsed electric field ablation instrument disconnects the electrode path that needs protection determined according to the cardiac electrophysiology 3D mapping system to ensure that the energy output will not pass through this electrode path , effectively ensuring the safety of ablation.
7.6脉冲电场消融仪在消融的过程中根据以上的信息去智能的切换电极通路,保证了电极通路在有效的贴靠以及需要继续治疗的位置进行消融。在这个过程中,脉冲电场消融仪会将所使能的电极通路的信息实时传送给心脏电生理三维标测系统。心脏电生理三维标测系统就可以根据此信息在消融模型上标注实际的放电点。采用此方法标注的放电点就可以指示切实有效的消融点,这样术者就可以依据此放电点判断消融区域是否达到了要求,进而使患者获得更有效的治疗。7.6 During the ablation process, the pulsed electric field ablation instrument switches the electrode path intelligently according to the above information, so as to ensure that the electrode path is effectively attached to the position where the treatment needs to be continued for ablation. During this process, the pulsed electric field ablation instrument will transmit the information of the enabled electrode pathway to the cardiac electrophysiology three-dimensional mapping system in real time. The cardiac electrophysiology 3D mapping system can mark the actual discharge points on the ablation model according to this information. The discharge point marked by this method can indicate the effective ablation point, so that the operator can judge whether the ablation area meets the requirements according to the discharge point, so that the patient can obtain more effective treatment.
以上显示和描述了本发明的基本原理和主要特征及本发明的优点,对于本领域技术人员而言,显然在不背离本发明的精神或基本特征的情况下,能够以其他的具体形式实现本发明。因此,无论从哪一点来看,均应将实施例看作是示范性的,而且是非限制性的,本发明的范围由所附权利要求而不是上述说明限定,因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。不应将权利要求中的任何附图标记视为限制所涉及的权利要求。The basic principles and main features of the present invention and the advantages of the present invention have been shown and described above. It is obvious to those skilled in the art that the present invention can be implemented in other specific forms without departing from the spirit or basic features of the present invention. invention. Therefore, the embodiments are to be regarded in all respects as illustrative and not restrictive, and the scope of the invention is to be defined by the appended claims rather than the foregoing description, which are therefore intended to fall within the scope of the claims. All changes within the meaning and scope of the equivalents of , are included in the present invention. Any reference signs in the claims shall not be construed as limiting the involved claim.
此外,应当理解,虽然本说明书按照实施方式加以描述,但并非实施方式仅包含一个独立的技术方案,说明书的这种叙述方式仅仅是为清楚起见,本领域技术人员应当将说明书作为一个整体,实施例中的技术方案也可以经适当组合,形成本领域技术人员可以理解的其他实施方式。In addition, it should be understood that although this specification is described according to an embodiment, it does not mean that the embodiment only includes an independent technical solution. This description in the specification is only for the sake of clarity. Those skilled in the art should take the specification as a whole and implement the The technical solutions in the examples can also be appropriately combined to form other embodiments that can be understood by those skilled in the art.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210583013.0A CN114948174B (en) | 2022-05-26 | 2022-05-26 | A pulsed electric field ablation system with intelligent control output channels |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210583013.0A CN114948174B (en) | 2022-05-26 | 2022-05-26 | A pulsed electric field ablation system with intelligent control output channels |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114948174A true CN114948174A (en) | 2022-08-30 |
CN114948174B CN114948174B (en) | 2024-11-26 |
Family
ID=82956329
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210583013.0A Active CN114948174B (en) | 2022-05-26 | 2022-05-26 | A pulsed electric field ablation system with intelligent control output channels |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114948174B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115414110A (en) * | 2022-09-09 | 2022-12-02 | 上海阿法钛医疗器械有限公司 | Impedance-based energy control method, system, and pulsed electric field ablation system |
US12076071B2 (en) | 2020-08-14 | 2024-09-03 | Kardium Inc. | Systems and methods for treating tissue with pulsed field ablation |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090093713A1 (en) * | 2007-10-04 | 2009-04-09 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Vasculature and lymphatic system imaging and ablation associated with a local bypass |
US20110098695A1 (en) * | 2009-10-27 | 2011-04-28 | Vivant Medical,Inc. | System and Method for Monitoring Ablation Size |
CN106388932A (en) * | 2016-07-12 | 2017-02-15 | 上海睿刀医疗科技有限公司 | Irreversible electroporation equipment |
CN107184270A (en) * | 2017-05-05 | 2017-09-22 | 上海安臻医疗科技有限公司 | A kind of adherent feedback method of radio frequency ablation system |
CN107635463A (en) * | 2015-05-12 | 2018-01-26 | 纳维斯国际有限公司 | Analyzed by dielectric property and carry out contact quality assessment |
CN110693605A (en) * | 2019-09-29 | 2020-01-17 | 四川锦江电子科技有限公司 | High-voltage pulse system for cardiac ablation |
CN111167008A (en) * | 2013-12-05 | 2020-05-19 | 免疫系统公司 | Cancer immunotherapy with radiofrequency electrical membrane breakdown (RF-EMB) |
CN113768616A (en) * | 2021-10-20 | 2021-12-10 | 四川锦江电子科技有限公司 | Integrated system for cardiac ablation |
CN114010309A (en) * | 2021-11-03 | 2022-02-08 | 成都科莱弗生命科技有限公司 | Ablation system |
-
2022
- 2022-05-26 CN CN202210583013.0A patent/CN114948174B/en active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090093713A1 (en) * | 2007-10-04 | 2009-04-09 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Vasculature and lymphatic system imaging and ablation associated with a local bypass |
US20110098695A1 (en) * | 2009-10-27 | 2011-04-28 | Vivant Medical,Inc. | System and Method for Monitoring Ablation Size |
CN111167008A (en) * | 2013-12-05 | 2020-05-19 | 免疫系统公司 | Cancer immunotherapy with radiofrequency electrical membrane breakdown (RF-EMB) |
CN107635463A (en) * | 2015-05-12 | 2018-01-26 | 纳维斯国际有限公司 | Analyzed by dielectric property and carry out contact quality assessment |
US20180116751A1 (en) * | 2015-05-12 | 2018-05-03 | Navix International Limited | Contact quality assessment by dielectric property analysis |
CN106388932A (en) * | 2016-07-12 | 2017-02-15 | 上海睿刀医疗科技有限公司 | Irreversible electroporation equipment |
CN107184270A (en) * | 2017-05-05 | 2017-09-22 | 上海安臻医疗科技有限公司 | A kind of adherent feedback method of radio frequency ablation system |
CN110693605A (en) * | 2019-09-29 | 2020-01-17 | 四川锦江电子科技有限公司 | High-voltage pulse system for cardiac ablation |
CN113768616A (en) * | 2021-10-20 | 2021-12-10 | 四川锦江电子科技有限公司 | Integrated system for cardiac ablation |
CN114010309A (en) * | 2021-11-03 | 2022-02-08 | 成都科莱弗生命科技有限公司 | Ablation system |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12076071B2 (en) | 2020-08-14 | 2024-09-03 | Kardium Inc. | Systems and methods for treating tissue with pulsed field ablation |
CN115414110A (en) * | 2022-09-09 | 2022-12-02 | 上海阿法钛医疗器械有限公司 | Impedance-based energy control method, system, and pulsed electric field ablation system |
Also Published As
Publication number | Publication date |
---|---|
CN114948174B (en) | 2024-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113768616B (en) | Integrated system for cardiac ablation | |
EP2510894B1 (en) | System for process monitoring and intelligent shut-off | |
EP1592355B1 (en) | Ablation system | |
US7250048B2 (en) | Ablation system and method of use | |
EP1401346B1 (en) | Ablation system | |
EP2474282B1 (en) | System for measuring current of an electrosurgical generator | |
EP1389966B1 (en) | Radiofrequency ablation system | |
US8262652B2 (en) | Imaginary impedance process monitoring and intelligent shut-off | |
US9375254B2 (en) | Seal and separate algorithm | |
EP2103269A1 (en) | Variable capacitive electrode pad | |
CN110693605A (en) | High-voltage pulse system for cardiac ablation | |
CN114948174A (en) | Intelligent pulsed electric field ablation system for controlling output channel | |
CN208274617U (en) | A kind of RF ablation and Mapping System of interpolar discharge | |
CN114010309B (en) | ablation system | |
CN119279752A (en) | Real-time feedback pulse ablation system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: No. 5, Wuke East 3rd Road, Wuhou District, Chengdu, Sichuan 610000 Applicant after: Sichuan Jinjiang Electronic Medical Device Technology Co.,Ltd. Address before: 610045 Sichuan city of Chengdu province Wuhou District three Vuko East Road No. 5 Applicant before: SICHUAN JINJIANG ELECTRONIC SCIENCE AND TECHNOLOGY Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |